Green Cross Lab Cell Corporation (144510) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.001x

Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has a cash flow conversion efficiency ratio of 0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩208.25 Million ≈ $141.13K USD) by net assets (₩189.35 Billion ≈ $128.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Green Cross Lab Cell Corporation (144510) total market value for the company's overall valuation and market capitalisation.

Green Cross Lab Cell Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Green Cross Lab Cell Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Green Cross Lab Cell Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross Lab Cell Corporation ranked by their cash flow conversion efficiency. Explore 144510 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
JTC Inc KQ:950170	0.048x
Espey Mfg & Electronics Corp NYSE MKT:ESP	0.112x
Simmtech Holdings Co. Ltd KQ:036710	0.037x
Humm Group Ltd AU:HUM	0.046x
Punjab Chemicals & Crop Protection Limited NSE:PUNJABCHEM	0.207x
Lucky Cement Co TW:1108	0.003x
6K Additive Inc AU:6KA	-0.226x
GRIGEO AB EO -29 F:WM8	0.033x

Annual Cash Flow Conversion Efficiency for Green Cross Lab Cell Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of Green Cross Lab Cell Corporation from 2015 to 2025. View latest Green Cross Lab Cell Corporation stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩190.38 Billion ≈ $129.02 Million	₩9.19 Billion ≈ $6.23 Million	0.048x	+94.89%
2024-12-31	₩457.79 Billion ≈ $310.24 Million	₩11.34 Billion ≈ $7.69 Million	0.025x	+265.48%
2023-12-31	₩541.48 Billion ≈ $366.95 Million	₩3.67 Billion ≈ $2.49 Million	0.007x	-94.50%
2022-12-31	₩538.46 Billion ≈ $364.91 Million	₩66.42 Billion ≈ $45.01 Million	0.123x	+163.63%
2021-12-31	₩511.00 Billion ≈ $346.30 Million	₩23.91 Billion ≈ $16.20 Million	0.047x	-75.73%
2020-12-31	₩47.17 Billion ≈ $31.97 Million	₩9.09 Billion ≈ $6.16 Million	0.193x	+3707.58%
2019-12-31	₩44.05 Billion ≈ $29.85 Million	₩223.04 Million ≈ $151.15K	0.005x	-50.78%
2018-12-31	₩47.72 Billion ≈ $32.34 Million	₩490.92 Million ≈ $332.69K	0.010x	-82.63%
2017-12-31	₩48.32 Billion ≈ $32.75 Million	₩2.86 Billion ≈ $1.94 Million	0.059x	+1059.97%
2016-12-31	₩48.10 Billion ≈ $32.59 Million	₩-296.65 Million ≈ $-201.04K	-0.006x	-103.71%
2015-12-31	₩8.96 Billion ≈ $6.07 Million	₩1.49 Billion ≈ $1.01 Million	0.166x	--

About Green Cross Lab Cell Corporation

KQ:144510 Korea Diagnostics & Research

Market Cap

$140.94 Million

₩207.98 Billion KRW

Market Cap Rank

#17979 Global

#773 in Korea

Share Price

₩13840.00

Change (1 day)

-2.33%

52-Week Range

₩12710.00 - ₩27500.00

All Time High

₩126167.70